PRJNA685845
Optimized polyepitope neoantigen DNA vaccines elicit neoantigens-specific immune responses in preclinical models and in clinical translation
Mouse breast cancer cell lines along with matched normal (tail) data from the animals in which they were grown. These data were used as a pre-clinical model for polyepitope neoantigen DNA vaccines.